Tenax Therapeutics

$1.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.82%) As of 8:50 AM EDT pre-market

Why Robinhood?

You can buy or sell TENX and other stocks, options, and ETFs commission-free!

About TENX

Tenax Therapeutics, Inc. Common Stock, also called Tenax Therapeutics, is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. Read More The company has a world-class scientific advisory team, including recognized global experts in pulmonary hypertension. The company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding its Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. The listed name for TENX is Tenax Therapeutics, Inc. Common Stock.

Employees
9
Headquarters
Morrisville, North Carolina
Founded
1967
Market Cap
15.27M
Price-Earnings Ratio
Dividend Yield
Average Volume
169.88K
High Today
$1.23
Low Today
$1.19
Open Price
$1.23
Volume
80.93K
52 Week High
$2.68
52 Week Low
$0.25

Collections

TENX Earnings

-$0.42
-$0.28
-$0.14
-$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, After Hours

You May Also Like